Steven Kalkanis, MD, director of neurosurgical oncology at Henry Ford West Bloomfield Hospital, discusses how an MRI unit in the operating suite has transformed their approach to brain surgery.
[[{"type":"media","view_mode":"media_crop","fid":"11555","attributes":{"alt":"Kalkanis ","class":"media-image media-image-left","id":"media_crop_9093605711970","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"215","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"margin: 0px; float: left;","title":"","typeof":"foaf:Image"}}]]In the world of brain surgery, millimeters matter. Yet when an incision is made, the brain and fluid shifts, rendering pre-operative images less accurate for mapping the brain, said Steven Kalkanis, MD, co-director of the Hermelin Brain Tumor Center and director of neurosurgical oncology at Henry Ford West Bloomfield Hospital.
The solution? An MRI system in the operating suite that allows for mid-surgery scans for image-guided surgery. Henry Ford recently implemented an interoperative MRI suite that can provide more a precise, real-time picture of the brain.
“Being able to take these images as we are removing the tumor allows us to map and navigate and protect tissue that needs to be protected and remove malignant brain tissue,” Kalkanis said.
The technology has transformed the team’s approach to brain surgery. In this podcast, Kalkanis discusses the implications of this “game changer” technology and how they managed the implementation.
Dual-room suites for MR and surgery. Image courtesy Phillips
Current Insights and Emerging Roles for Contrast-Enhanced Mammography
May 10th 2024In a recent lecture at the 2024 ARRS Annual Meeting, Jordana Phillips, MD, discussed the role of contrast-enhanced mammography in staging breast cancer, evaluating response to neoadjuvant chemotherapy and recalls from screening.
MRI-Based Deep Learning Algorithm Shows Comparable Detection of csPCa to Radiologists
May 8th 2024In a study involving over 1,000 visible prostate lesions on biparametric MRI, a deep learning algorithm detected 96 percent of clinically significant prostate cancer (csPCa) in comparison to a 98 percent detection rate for an expert genitourinary radiologist.
Breast MRI and Dense Breasts: A Closer Look at Early Findings from a New Prospective Trial
May 2nd 2024Supplemental breast MRI had a cancer detection rate (CDR) of 20/1000 and a positive predictive value (PPV) of 50 percent, according to preliminary findings from a prospective trial involving women with heterogeneously or very dense breasts.